NEXUS PHARMACEUTICALS, LLC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	2	1
2024	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
DLA PIPER LLP (US)	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	2
SENATE	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	3

NEXUS PHARMACEUTICALS, LLC — Lobbying Disclosure | Poliscope